Last year, almost 300 people attended the most important event on Big Data and Genomics - BioData World Congress. The 2016 event has been developed with the one goal of driving precision medicine into the clinic in the most streamlined and effective way possible:
- Bringing together clinicians, big pharma, biotech institutions, policy makers, visionary academics and data leaders to facilitate partnerships and drive progress.
- Reviewing game changing innovation, roadblocks, and critical success factors in the practical application of big data.
- Understanding how big data is driving developments in personalised medicine.
Precision medicine is only attainable through bringing together the world's principal decision makers involved in this multidisciplinary effort to one platform.
This is why the world's leading international institutions have supported the series to make this a reality. These institutions include: The Wellcome Trust Sanger Institute, EMBL-EBI, Global Alliance for Genomics and Health, Babraham Institute, ABPI, Pharmacogenetics and Stratified Medicine Network, BIA, Pistoia Alliance, Cancer Research UK, The Farr Institute and The Francis Crick Institute.
Our 90+ international speaker panel includes board or director level speakers from the following institutions:
- EMBL-EBI
- Genomics England
- The Institute of Cancer Research
- Farr Institute
- Teva Pharmaceuticals
- Wellcome Trust Sanger Institute
- AstraZeneca
- Cancer Research UK
- Genomics England
- Public Health England
- Novartis
...and many more!
Don't miss this unprecedented opportunity to be right at the cutting edge of life science research.